Who
Stephen Michael Moore
SVP and Chief Legal Officer
Company insider
Files Form 4 as: SVP and Chief Legal Officer, Personalis.
In numbers
- Trades disclosed
- 31
- Buys
- 0
- Sells
- 17
- Bought
- $0
- Sold
- $172K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 May 2022
- Last trade
- 18 Sep 2026
- Last filed
- 22 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Sep 2026filed 22 Sep 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $34K2,068 at $16.22 | filing |
| 18 Sep 2026filed 22 Sep 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $34K2,068 at $16.22 | filing |
| 15 Mar 2026filed 17 Mar 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code A | —28,125 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —168,750 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —168,750 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code A | —28,125 at $0.00 | filing |
| 23 Feb 2026filed 25 Feb 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —8,333 at $0.00 | filing |
| 23 Feb 2026filed 25 Feb 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —8,333 at $0.00 | filing |
| 16 May 2025filed 20 May 2025 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $8,2911,675 at $4.95 | filing |
| 15 Mar 2025filed 18 Mar 2025 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 16 Dec 2024filed 18 Dec 2024 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $5,7801,513 at $3.82 | filing |
| 18 Nov 2024filed 20 Nov 2024 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $6,4161,693 at $3.79 | filing |
| 17 Jun 2024filed 20 Jun 2024 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $2,0451,585 at $1.29 | filing |
| 17 May 2024filed 21 May 2024 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $2,3891,731 at $1.38 | filing |
| 30 Apr 2024filed 2 May 2024 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $6,1974,523 at $1.37 | filing |
| 15 Mar 2024filed 19 Mar 2024 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 15 Dec 2023filed 19 Dec 2023 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $2,1701,476 at $1.47 | filing |
| 16 Nov 2023filed 20 Nov 2023 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $1,7911,722 at $1.04 | filing |
| 16 Jun 2023filed 21 Jun 2023 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $3,1241,509 at $2.07 | filing |
| 17 May 2023filed 19 May 2023 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $3,5261,781 at $1.98 | filing |
News
No headline names them, or the companies they trade most, lately.